Source: Business Wire

Press Release: Eli Lilly : CHMP issues positive opinion for Jardiance (empagliflozin) for the treatment of adults with heart failure with reduced ejection fraction

INGELHEIM, Germany--(BUSINESS WIRE)--CHMP issues positive opinion for Jardiance® (empagliflozin) for the treatment of adults with heart failure with reduced ejection fraction

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
$25.5B
Employees
38,680
David A. Ricks's photo - Chairman & CEO of Eli Lilly

Chairman & CEO

David A. Ricks

CEO Approval Rating

65/100

Read more